Premium
Impact of OATP1B1, MDR1 and CYP3A4 expression in liver and intestine on interpatient pharmacokinetic variability of atorvastatin in obese subjects
Author(s) -
Ulvestad M,
Skottheim I. B.,
Signe Jakobsen G,
Bremer S,
Molden E,
Åsberg A,
Hjelmesæth Jøran,
Andersson T. B.,
Sandbu R,
Christensen H
Publication year - 2015
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.70
Subject(s) - slco1b1 , atorvastatin , pharmacogenetics , pharmacology , genotyping , medicine , pharmacokinetics , transporter , clinical pharmacology , cyp3a4 , gastroenterology , biology , genotype , genetics , gene , metabolism , cytochrome p450